APA

Wilke R. A., Ramsey L. B., Johnson S. G., Maxwell W. D., McLeod H. L., Voora D., Krauss R. M., Roden D. M., Feng Q., Cooper-Dehoff R. M., Gong L., Klein T. E., Wadelius M. & Niemi M. (20120904). The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. : Clinical pharmacology and therapeutics.

Chicago

Wilke R A, Ramsey L B, Johnson S G, Maxwell W D, McLeod H L, Voora D, Krauss R M, Roden D M, Feng Q, Cooper-Dehoff R M, Gong L, Klein T E, Wadelius M and Niemi M. 20120904. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. : Clinical pharmacology and therapeutics.

Harvard

Wilke R. A., Ramsey L. B., Johnson S. G., Maxwell W. D., McLeod H. L., Voora D., Krauss R. M., Roden D. M., Feng Q., Cooper-Dehoff R. M., Gong L., Klein T. E., Wadelius M. and Niemi M. (20120904). The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. : Clinical pharmacology and therapeutics.

MLA

Wilke R A, Ramsey L B, Johnson S G, Maxwell W D, McLeod H L, Voora D, Krauss R M, Roden D M, Feng Q, Cooper-Dehoff R M, Gong L, Klein T E, Wadelius M and Niemi M. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. : Clinical pharmacology and therapeutics. 20120904.